Prognosis of immune checkpoint inhibitor-induced myasthenia gravis: a single center experience and systematic review

BackgroundImmune checkpoint inhibitors (ICI)-induced myasthenia gravis (MG) is an uncommon but potentially fatal neurotoxicity. We aim to help physicians familiarize themselves with the clinical characteristics of ICI-induced MG, facilitating early diagnosis and prompt intervention.MethodsWe searche...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yuhui Qin, Siyuan Chen, Qian Gui, Teng Zhang, Yanan Li, Zhijuan Du, Yahui Lv, Xiangyu Du, Yi Hu, Zhefeng Liu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2024-04-01
Colecção:	Frontiers in Neurology
Assuntos:	myasthenia gravis immune checkpoint inhibitors immunotherapy immune-related adverse events neurotoxicity
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fneur.2024.1372861/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!